том 142 страницы 240-250

Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats

Тип публикацииJournal Article
Дата публикации2018-11-01
scimago Q1
wos Q1
БС1
SJR1.589
CiteScore9.4
Impact factor4.6
ISSN00283908, 18737064
Pharmacology
Cellular and Molecular Neuroscience
Краткое описание
2,5-Dimethoxyphenethylamines (2C compounds) are 5-HT2A/2C receptor agonists that induce hallucinogenic effects. N-methoxybenzylation of 2C compounds markedly increases their affinity for 5-HT2A receptors, and two such analogs, 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe) and 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe), have emerged in recreational drug markets. Here, we investigated the neuropharmacology of 25C-NBOMe and 25I-NBOMe in rats, as compared to their 2C analogs and the prototypical 5-HT2A/2C agonist 1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine (DOI). Compounds were tested in vitro using 5-HT2A receptor binding and calcium mobilization assays. For in vivo experiments, 25C-NBOMe (0.01–0.3 mg/kg), 25I-NBOMe (0.01–0.3 mg/kg), 2-(4-chloro-2,5-dimethoxyphenyl)ethanamine (2C-C) (0.1–3.0 mg/kg), 2-(4-iodo-2,5-dimethoxyphenyl)ethanamine (2C-I) (0.1–3.0 mg/kg) and DOI (0.03–1.0 mg/kg) were administered subcutaneously (sc) to male rats, and 5-HT2A-mediated behaviors were assessed. NBOMes displayed higher affinity for 5-HT2A receptors than their 2C counterparts but were substantially weaker in functional assays. 25C-NBOMe and 25I-NBOMe were much more potent at inducing wet dog shakes (WDS) and back muscle contractions (BMC) when compared to 2C-C and 2C-I. Pretreatment with the selective 5-HT2A antagonist (R)-(2,3-dimethoxyphenyl){1-[2-(4-fluorophenyl)ethyl]-4-piperidinyl}methanol (M100907) reversed behaviors produced by all agonists. Interestingly, binding affinities at the 5-HT2A receptor were significantly correlated with potencies to induce BMC but not WDS. Our findings show that NBOMes are highly potent 5-HT2A agonists in rats, similar to effects in mice, and consistent with the reported hallucinogenic effects in human users. This article is part of the Special Issue entitled ‘Psychedelics: New Doors, Altered Perceptions’.
Найдено 
Найдено 

Топ-30

Журналы

1
2
3
4
5
Neuropharmacology
5 публикаций, 9.09%
ACS Chemical Neuroscience
5 публикаций, 9.09%
ACS Pharmacology & Translational Science
4 публикации, 7.27%
Archives of Toxicology
4 публикации, 7.27%
International Journal of Molecular Sciences
3 публикации, 5.45%
Frontiers in Pharmacology
2 публикации, 3.64%
Neurotoxicity Research
2 публикации, 3.64%
Molecular Psychiatry
2 публикации, 3.64%
Drug Testing and Analysis
1 публикация, 1.82%
Brain Sciences
1 публикация, 1.82%
Metabolites
1 публикация, 1.82%
Molecules
1 публикация, 1.82%
Frontiers in Neuroscience
1 публикация, 1.82%
Frontiers in Psychiatry
1 публикация, 1.82%
International Journal of Legal Medicine
1 публикация, 1.82%
Pharmacological Reports
1 публикация, 1.82%
Brain Research Bulletin
1 публикация, 1.82%
Forensic Science International
1 публикация, 1.82%
Critical Reviews in Toxicology
1 публикация, 1.82%
Biochemical Pharmacology
1 публикация, 1.82%
Annals of the New York Academy of Sciences
1 публикация, 1.82%
Journal of Neurochemistry
1 публикация, 1.82%
Addiction Biology
1 публикация, 1.82%
Analytical Chemistry
1 публикация, 1.82%
Journal of Analytical Toxicology
1 публикация, 1.82%
European Journal of Pharmacology
1 публикация, 1.82%
Archives of Pharmacal Research
1 публикация, 1.82%
ACS Omega
1 публикация, 1.82%
Behavioural Pharmacology
1 публикация, 1.82%
1
2
3
4
5

Издатели

2
4
6
8
10
12
Springer Nature
12 публикаций, 21.82%
Elsevier
12 публикаций, 21.82%
American Chemical Society (ACS)
11 публикаций, 20%
MDPI
6 публикаций, 10.91%
Wiley
4 публикации, 7.27%
Frontiers Media S.A.
4 публикации, 7.27%
Cold Spring Harbor Laboratory
2 публикации, 3.64%
Taylor & Francis
1 публикация, 1.82%
Society of Forensic Toxicologists
1 публикация, 1.82%
Ovid Technologies (Wolters Kluwer Health)
1 публикация, 1.82%
SAGE
1 публикация, 1.82%
2
4
6
8
10
12
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
55
Поделиться
Цитировать
ГОСТ |
Цитировать
Elmore J. S. et al. Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats // Neuropharmacology. 2018. Vol. 142. pp. 240-250.
ГОСТ со всеми авторами (до 50) Скопировать
Elmore J. S., Decker A. M., Sulima A., Rice K. C., PARTILLA J. S., Blough B. E., A Baumann M. Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats // Neuropharmacology. 2018. Vol. 142. pp. 240-250.
RIS |
Цитировать
TY - JOUR
DO - 10.1016/j.neuropharm.2018.02.033
UR - https://doi.org/10.1016/j.neuropharm.2018.02.033
TI - Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats
T2 - Neuropharmacology
AU - Elmore, Joshua S.
AU - Decker, Ann Marie
AU - Sulima, Agnieszka
AU - Rice, K. C.
AU - PARTILLA, JOHN S.
AU - Blough, Bruce E.
AU - A Baumann, Michael
PY - 2018
DA - 2018/11/01
PB - Elsevier
SP - 240-250
VL - 142
PMID - 29501528
SN - 0028-3908
SN - 1873-7064
ER -
BibTex
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2018_Elmore,
author = {Joshua S. Elmore and Ann Marie Decker and Agnieszka Sulima and K. C. Rice and JOHN S. PARTILLA and Bruce E. Blough and Michael A Baumann},
title = {Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats},
journal = {Neuropharmacology},
year = {2018},
volume = {142},
publisher = {Elsevier},
month = {nov},
url = {https://doi.org/10.1016/j.neuropharm.2018.02.033},
pages = {240--250},
doi = {10.1016/j.neuropharm.2018.02.033}
}